About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
ELCC 2019: European Lung Cancer Congress
AACR Annual Meeting 2019
NCCN Annual Conference 2019
2019 SGO Annual Meeting on Womens Cancer
2019 Multidisciplinary Thoracic Cancers Symposium
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
2016 ASH Annual Meeting
Today In Oncology
DNA Rearrangement May Predict Treatment Resistance and Poor Outcomes in Multiple Myeloma
Does Squamous Cell Carcinoma Risk Change With Immunosuppression?
Does Oncotype DX–Guided Treatment Reduce Initial Costs of Breast Cancer Care?
Combined Crowd Innovation and AI in Producing Algorithms for Radiotherapy Targeting
Low-Dose Tamoxifen vs Placebo in Preventing Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia
Most Read Stories
'Oral Cryotherapy' for Patients Undergoing Oxaliplatin-Based Chemotherapy
Complementary and Alternative Medicine Use in Patients With Cancer
ASCO and ASH Release Update to Clinical Practice Guidelines for Use of Erythropoiesis-Stimulating Agents
Follow-up of Adjuvant Paclitaxel and Trastuzumab in Small HER2-Positive Breast Tumors
KEYNOTE-158: Pembrolizumab in Previously Treated Advanced Cervical Cancer
Most Viewed Videos
Heather A. Wakelee, MD, on Advanced Non–Small Cell Lung Cancer: State-of-the-Art Treatment for EGFR-Positive and ALK-Positive Diseases
Eva M. Ciruelos, MD, PhD, on HER2-Positive Breast Cancer: Results From the PATRICIA Trial
Martin Edelman, MD, on Immunotherapy: How Safe Is It for Patients With Autoimmune Disease?
Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial
Jyoti D. Patel, MD, on Stage III Non–Small Cell Lung Cancer: A Look at New Systemic Treatments
© 2019 HSP News Service, L.L.C.